Product | Indication | Drug discovery | Lead optimization | Non-clinical study | Phase Ⅰ | Phase Ⅱ | Phase Ⅲ |
---|---|---|---|---|---|---|---|
SC-01 | Breast cancer | ||||||
SC-02 | NSCLC Glioma |
||||||
SC-04 | Neurodegenerative disorders | ||||||
SC-05 | Ovarian cancer Endometriosis |
||||||
SC-06 | Hematological neoplasms |
SC-01

Drug discovery | Lead optimization | Non-clinical study | Phase Ⅰ | Phase Ⅱ | Phase Ⅲ |
---|---|---|---|---|---|
SC-02

Drug discovery | Lead optimization | Non-clinical study | Phase Ⅰ | Phase Ⅱ | Phase Ⅲ |
---|---|---|---|---|---|
SC-04

Drug discovery | Lead optimization | Non-clinical study | Phase Ⅰ | Phase Ⅱ | Phase Ⅲ |
---|---|---|---|---|---|
SC-05

Drug discovery | Lead optimization | Non-clinical study | Phase Ⅰ | Phase Ⅱ | Phase Ⅲ |
---|---|---|---|---|---|
SC-06

Drug discovery | Lead optimization | Non-clinical study | Phase Ⅰ | Phase Ⅱ | Phase Ⅲ |
---|---|---|---|---|---|